Medication-Assisted Treatment (MAT)

Medication-assisted treatment (MAT), including opioid treatment programs (OTPs), combines behavioral therapy and medications to treat substance use disorders.

Nurse practitioners (NPs) and physician assistants (PAs) can now train and apply to become DATA-Waiver practitioners. Learn more and sign up for training.

Review SAMHSA's proposed learning objectives for the NP and PA waiver training.

To prescribe or dispense buprenorphine, physicians must qualify and apply for a waiver under the Drug Addiction Treatment Act of 2000 (DATA 2000).

Physicians can complete the Online Request for Patient Limit Increase.

Physicians are also required to complete buprenorphine training.

Learn more about how to:

Physicians can join the SAMHSA Buprenorphine Clinical Discussion WebBoard to ask and discuss questions on the clinical use of buprenorphine.

A combination of medication and counseling and behavioral therapy is effective in treating alcohol and opioid dependency.

Find information on physical ailments often diagnosed in MAT patients. Also known as common comorbidities, these include viral hepatitis, HIV, and AIDS.

Last Updated: 11/22/2016